Gene Therapy: From Bench to Bedside Series
ORLANDO, Fla. (Ivanhoe Newswire) – 20,000 Americans are living with hemophilia, a condition that prevents the blood from clotting easily after a cut or injury. Patients are also more susceptible to internal bleeding – which can damage joints, organs and tissue. Researchers are now testing gene therapies for both types of hemophilia – type A and type B. Both therapies are designed to help blood clot better.
PHILIDELPHIA, Pa. (Ivanhoe Newswire) -- It’s a form of blindness that some call “especially cruel”. People with choroideremia are born with perfect vision and then begin to lose their sight, sometimes as kids or teens. Researchers in the United States are now building on the success of a clinical trial overseas and are about to test a therapy designed to halt the progression of the disease and maybe even reverse some of the damage.
PHILLADELPHIA, Pa. (Ivanhoe Newswire) -- For the first-time ever, doctors at the University of Pennsylvania have successfully used personalized gene therapy in a dozen patients with HIV, knocking the virus down to the point where it was almost completely undetectable. Researchers say it’s a huge win in the fight against aids and HIV, and brings them closer than ever to a cure.
This search brought to you by ClinicalTrials.gov. Search other clinical trial listings on the Internet at CenterWatch.
Powered by Local.com